GnRH receptor antagonists for prostate cancer

    loading  Checking for direct PDF access through Ovid

Abstract

GnRH receptor antagonists can reduce testosterone levels without the adverse reactions caused by other drugs used to treat prostate cancer. These drugs also offer hope for prolonged control of metastasis.

Related Topics

    loading  Loading Related Articles